Protein arginine methyltransferases (PRMTs) function as molecular rheostats that tip mitochondrial stress responses in muscle and motor neurons toward either adaptive resolution or degenerative collapse — a mechanistic framing proposed by researchers at Sungkyunkwan University. Distinct PRMT family members operate non-redundantly across muscle fibers, satellite cells, and motor neurons, intersecting with AMPK-FOXO and mTOR signaling to regulate mitochondrial biogenesis, mitophagy, proteostatic balance, and anabolic restraint.
This conceptual synthesis arrives at a productive moment. Sarcopenia research has long focused on protein turnover and anabolic signaling, but the upstream epigenetic and post-translational machinery coordinating mitochondrial quality control has been undercharacterized. PRMTs — best known for histone arginine methylation — are increasingly recognized as non-epigenetic signal modulators, making this reframing genuinely useful for the field. The proposed PRMT-AMPK-mTOR axis offers a plausible unifying mechanism connecting redox imbalance, neuromuscular junction instability, and motor unit loss that no single pathway previously explained well.
However, this is a perspective or review-style synthesis, not a primary experimental study — no original cohort data, animal models, or effect sizes are reported. Its value lies in hypothesis generation rather than causal demonstration. Practically, PRMT modulation remains years from clinical translation, though existing PRMT inhibitors in oncology trials could accelerate mechanistic studies in aged muscle. Incremental but intellectually clarifying for researchers in muscle biology and aging.
